MedTrace Logo

Home-based Care and Hand Hygiene Interventions in Honduras

NCT04886414 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1821

Last updated 2025-05-14

No results posted yet for this study

Summary

This study aims to enroll patients with acute infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) who do not meet criteria for hospital admission according to protocols developed by the Honduras Ministry of Health (MOH). Patients who are triaged to home must also be over the age of 60 years or have one high risk comorbidity and be over 45 years in order to meet inclusion criteria. These patients will be randomly assigned to one of four home-based care strategies, which may or may not include regular blood oxygenation monitoring and provision of alcohol-based hand-rub. Patients will be followed until resolution of their acute illness, and data will be collected on feasibility, impact and acceptance of the intervention. Some patients will be followed for up to one year to monitor for post-Coronavirus Disease 2019 (COVID-19) symptoms.

Conditions

  • Covid19

Interventions

OTHER

Phone-based monitoring

Study staff will perform daily phone-based assessments using standardized electronic study tools (tablets). Clinical features will be documented on a phone-based patient monitoring form.

OTHER

Oxygen saturation monitoring

Oxygen saturation will be monitored and recorded at regular intervals.

OTHER

Alcohol-based hand sanitizer

Alcohol-based hand sanitizer will be distributed to subjects.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-31
Primary Completion
2023-01-15
Completion
2023-02-28

Countries

  • Honduras

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04886414 on ClinicalTrials.gov